AViTA Corporation (TPEX:4735)
Taiwan · Delayed Price · Currency is TWD 38.30
0.00 (0.00%)
Aug 26, 2026, 1:30 PM CST
AViTA Revenue
AViTA had revenue of 273.42M TWD in the quarter ending June 30, 2026, with 7.84% growth. This brings the company's revenue in the last twelve months to 972.61M, up 4.61% year-over-year. In the year 2025, AViTA had annual revenue of 936.39M with 0.98% growth.
Revenue (ttm)
972.61M
Revenue Growth
+4.61%
P/S Ratio
1.52
Revenue / Employee
11.58M
Employees
84
Market Cap
1.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 936.39M | 9.09M | 0.98% |
| Dec 31, 2024 | 927.30M | 48.22M | 5.48% |
| Dec 31, 2023 | 879.08M | -321.84M | -26.80% |
| Dec 31, 2022 | 1.20B | -1.12B | -48.35% |
| Dec 31, 2021 | 2.33B | -274.96M | -10.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.78B |
| Cowealth Medical Holding | 2.86B |
| Wellell | 2.50B |
| OK Biotech | 1.54B |
| Dynamic Medical Technologies | 1.40B |
| Bioptik Technology Incorporation | 912.86M |
| Diamond Biotechnology | 464.63M |
| Wiltrom | 314.09M |